← Leaderboards
John Brognard
Division Of Basic Sciences - Nci
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at Division Of Basic Sciences - Nci
Same institution · by research overlap
Others in their field
Top investigators on “Oncogenic”
- Ralph Parchment · Leidos Biomedical Research, Inc.$141,315,269
- David Heimbrook · Leidos Biomedical Research, Inc.$73,747,183
- Scott W Lowe · Sloan-Kettering Inst Can Research$36,382,798
- John Blenis · Harvard University (Medical School)$29,103,255
- Andrea Califano · Columbia University Health Sciences$28,006,523
- Robert Neil Eisenman · Fred Hutchinson Cancer Research Center$27,166,845
Research focus
OncogenicMalignant NeoplasmsMolecularTargeted TreatmentPhosphotransferasesTumorigenesisSmall Interfering RnaGenome EditingBioinformaticsGeneticGenomic ApproachFunctional GenomicsMutantStructural ModelsCritical PathwaysScreeningMutationDependenceTumorPathway InteractionsCancer GenomicsHead And Neck CancerAllelesBraf Gene
Grant awards (20)
Oncogenic Kinases in Cancer$1,563,970
ZIA · FY2025 · CA · contact PI
Novel Tumor Suppressing Kinases in Cancer$82,314
ZIA · FY2025 · CA · contact PI
Oncogenic Kinases in Cancer$2,038,007
ZIA · FY2024 · CA · contact PI
Novel Tumor Suppressing Kinases in Cancer$107,264
ZIA · FY2024 · CA · contact PI
Oncogenic Kinases in Cancer$1,809,446
ZIA · FY2023 · CA · contact PI
Novel Tumor Suppressing Kinases in Cancer$95,235
ZIA · FY2023 · CA · contact PI
Oncogenic Kinases in Cancer$2,017,257
ZIA · FY2022 · CA · contact PI
Novel Tumor Suppressing Kinases in Cancer$106,172
ZIA · FY2022 · CA · contact PI
Oncogenic Kinases in Cancer$1,433,387
ZIA · FY2021 · CA · contact PI
Novel Tumor Suppressing Kinases in Cancer$75,441
ZIA · FY2021 · CA · contact PI
Oncogenic Kinases in Cancer$1,637,395
ZIA · FY2020 · CA · contact PI
Novel Tumor Suppressing Kinases in Cancer$181,933
ZIA · FY2020 · CA · contact PI
Oncogenic Kinases in Cancer$1,359,286
ZIA · FY2019 · CA · contact PI
Novel Tumor Suppressing Kinases in Cancer$151,032
ZIA · FY2019 · CA · contact PI
Oncogenic Kinases in Cancer$1,161,229
ZIA · FY2018 · CA · contact PI
Novel Tumor Suppressing Kinases in Cancer$290,307
ZIA · FY2018 · CA · contact PI
Oncogenic Kinases in Cancer$1,099,330
ZIA · FY2017 · CA · contact PI
Novel Tumor Suppressing Kinases in Cancer$471,142
ZIA · FY2017 · CA · contact PI
Oncogenic Kinases in Cancer$317,913
ZIA · FY2016 · CA · contact PI
Novel Tumor Suppressing Kinases in Cancer$317,913
ZIA · FY2016 · CA · contact PI